Australia

  • 2024 A Year in Review

    2024 A Year in Review

    As we approach the close of 2024, it’s essential to reflect on our achievements, growth, and the incredible progress we’ve made together. This year has been transformative, marked by milestones that position the Adjutor Healthcare Group for even greater success in 2025. As we look forward, we remain committed to innovation, collaboration, and delivering exceptional…

  • Advertising and Promotional Material Review for Therapeutic Goods in Australia

    Advertising and Promotional Material Review for Therapeutic Goods in Australia

    Navigating advertising compliance for therapeutic goods in Australia can feel like walking a tightrope. With multiple advertising laws enforced by different regulators, businesses must tread carefully to avoid penalties or legal complications.

  • Cell and Gene Therapies Regulation

    Cell and Gene Therapies Regulation

    Navigating the Regulation of Cell and Gene Therapies in Australia and New Zealand Globally, cell and gene therapies are revolutionising modern medicine, offering groundbreaking treatments for life-threatening conditions including cancer, genetic disorders and rare diseases. However, despite the pace of scientific innovation, regulatory frameworks in many countries, including Australia and New Zealand, have struggled to…

  • Australian Government Cash Splash on High Tech Recovery

    Australian Government Cash Splash on High Tech Recovery

    Australian science and technology sectors are talking about a ‘research revival’ as the Federal Government splashes the cash in the 2020 Budget. 2020 Budget Cash Splash Thanks to COVID-19, early October saw the first Australian federal budget delivered in a recession in 30 years. The Treasurer said personal income tax cuts, infrastructure spending, and business

  • The Pointy End of the TGA (PI) Reformatting Transition Period

    The Pointy End of the TGA (PI) Reformatting Transition Period

    By now, we should all be very familiar with the new Form for providing Product Information (PI) for Australia. Each time you make a change to a PI, be it safety-related or otherwise, you’re required to provide the updated PI to TGA in the new format. The looming deadline for marketed product PIs to be

  • Consumer Insecurity / Vanity Targeted by TGA – Massive Fines

    Consumer Insecurity / Vanity Targeted by TGA – Massive Fines

    The appearance of misleading terms and claims on websites and social media has attracted the attention of the TGA. The Therapeutic Goods Administration in Australia (TGA) has advised that fines were imposed via the Federal Court for misleading advertising by Peptide Clinics Australia (Peptide Clinics Pty Ltd), to the tune of $10 million (for breaches…

  • Australian Employment Regulations

    Australian Employment Regulations

    Today, we are pleased to introduce one of our affiliates and guest blogger, Anna Pannuzzo from WorkPlacePLUS. In this post, Anna discusses some key workplace health, safety and other legal aspects of setting up or maintaining a sales office in Australia. Expanding your business can be an exciting time, but setting up abroad comes with…

  • Advertising Therapeutic Goods in Australia

    Advertising Therapeutic Goods in Australia

    If you’re advertising therapeutic goods in Australia in 2019, there’s new legislation that is critical to your successful campaign/s. We’ve been keeping up to date over the break to ensure we’re ready to assist our clients with all of their commercialization needs around the globe.